Freezing of Gait in Parkinson's Disease
Status: | Completed |
---|---|
Conditions: | Parkinsons Disease |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/25/2017 |
Start Date: | June 2013 |
End Date: | August 2014 |
Effect of Visuospatial Training Tasks on Freezing of Gait in Parkinson's Disease
This study is designed to evaluate whether a specific visuospatial training task will change
gait performance of Parkinson's disease (PD) patients in doorways, specifically freezing of
gait.
gait performance of Parkinson's disease (PD) patients in doorways, specifically freezing of
gait.
This study is a randomized, prospective, single-blinded six-week study in PD patients with
freezing of gait (FOG).
This study will involve 2 study groups:
Group A - training group; Group B - no training group/controls.
Both groups will complete a gait evaluation and neuropsychological testing. Group A will
also practice an in-home visuospatial task for 30 minutes, 4-6 days per week for six weeks.
Group B will not complete the in-home tasks.
Participation in this study is expected to last 6-8 weeks.
freezing of gait (FOG).
This study will involve 2 study groups:
Group A - training group; Group B - no training group/controls.
Both groups will complete a gait evaluation and neuropsychological testing. Group A will
also practice an in-home visuospatial task for 30 minutes, 4-6 days per week for six weeks.
Group B will not complete the in-home tasks.
Participation in this study is expected to last 6-8 weeks.
Inclusion Criteria:
- Age: greater than 18 years old and without an upper age limit
- diagnosis of idiopathic PD exhibiting at least 2 or 3 cardinal signs (bradykinesia,
rigidity, and resting tremor)
- Ambulate independently without an assistive device for at least 60 meters
- Freezing of gait episodes confirmed through the FOG-Q and evaluation by a fellowship
trained Movement Disorder neurologist
- Willingness and ability to participate in training and complete training diary
- Documented FOG-Q and Unified Parkinson's Disease Rating Scale (UPDRS) II
- Ability to sign informed consent
- Pregnant females will be included in the study and there are no known risks to the
pregnant female or fetus
Exclusion Criteria:
- Inability to complete questionnaires
- Unwillingness to participate in training, complete all questionnaires and training
diary
- Subjects with secondary causes of parkinsonism
- Significant dementia (MOCA <20)
- Prior deep brain stimulation (DBS) surgery or pallidotomy
- Subjects cannot participate in any form of Physical Therapy, Occupational Therapy or
Speech Therapy during the study period
- Subjects cannot start any new medications during the study period.
We found this trial at
1
site
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials